PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

IVF and IUI treatment cycles increase across Europe, along with stable pregnancy rates

Women in Europe are receiving more cycles of in vitro fertilization (IVF) and intrauterine insemination (IUI), according to data presented today at the ESHRE 40th Annual Meeting in Amsterdam

2024-07-09
(Press-News.org) Women in Europe are receiving more cycles of in vitro fertilisation (IVF) and intrauterine insemination (IUI), according to data presented today at the ESHRE 40th Annual Meeting in Amsterdam [1].

Preliminary data from the ESHRE European IVF Monitoring (EIM) Consortium [2] reveals a steady and progressive rise in the use of Assisted Reproductive Technology (ART). In 2021, a total of 1 103,633 ART treatment cycles were reported by 1,382 clinics across 37 European countries – a 20% increase from the 919,364 cycles reported in 2020, keeping in mind that this was the year COVID affected the number of treatment cycles [3].

Of these 2021 treatment cycles, 153,191 were IVF, 418,069 intracytoplasmic sperm injection (ICSI), 368,464 frozen embryo replacement, 78,432 preimplantation genetic testing, 79,510 egg donations, 415 in vitro maturation of oocytes, and 5,552 cycles with frozen oocyte replacement. In addition, data from 1,441 institutions reported 148,194 IUI treatments where the partner’s semen is used (31 countries) and 48,583 IUI treatments where donor semen is used (23 countries). A total of 28,768 fertility preservation interventions, including oocyte, ovarian tissue, semen, and testicular tissue banking, were reported from 15 countries.

Clinical pregnancy rates [4] per aspiration and per transfer remained similar in 2021 and 2020 for IVF (26.3% and 33.5 % in 2021 versus 25.4% and 33.2% in 2020) and for ICSI (23.9% and 33.5% in 2021 versus 25.2% and 33.0% 2020). Pregnancy rates per transfer for frozen embryo replacement with own embryos was slightly higher in 2021 (37.0%) versus 2020 (36.0%), as were pregnancy rates per fresh embryo transfer from egg donations (53.1% in 2021 versus 51.3% in 2020), while for frozen oocyte replacements the number decreased slightly (45.5% in 2021 versus 45.7% in 2020).

This reflects a 3.98% increase in the use of one embryo per transfer, rising from 57.9% in 2020 to 60.5% in 2021. The proportion of singleton, twin, and triplet deliveries was 90.4%, 9.5%, and 0.1% in 2021, respectively, compared to 88.9%, 10.9%, and 0.2% in 2020. Twin and triplet delivery rates after frozen embryo replacement were 6.9% and 0.1%, respectively, compared to 7.9% and 0.1% in 2020.

The lead author, Dr. Jesper Smeenk of Elisabeth-TweeSteden Hospital in Tilburg, Netherlands, stated: “The 25th ESHRE report on ART and IUI shows a continuous increase of reported treatment numbers and medically assisted reproduction (MAR)-derived live births in Europe. Being already the largest data collection on MAR in Europe, continuous efforts to stimulate data collection and reporting strive for future quality control and completeness of the data and offer higher transparency and vigilance in the field of reproductive medicine.”

Professor Dr. Karen Sermon, Chair of ESHRE, added: “This report underscores the significance of collaborative efforts and standardized reporting in advancing reproductive medicine. By enhancing data collection practices, we aim to elevate clinical standards and patient outcomes across Europe.”

 

Data collection and reporting:

The ESHRE EIM report represents the largest data collection on medically assisted reproduction in Europe. Since 1997, ART data aggregated by national registries, clinics, or professional societies have been collected and analysed by the EIM. This year's data, covering treatments from January 1 to December 31, 2021, were provided by national registries or medical associations from 37 European countries.

The authors note in their presentation that the findings should be interpreted with caution, as the methods of data collection and levels of completeness of reported data vary among European countries. 

ENDS

 

Notes to editors:

A reference to the ESHRE Annual Meeting must be included in all coverage and/or articles associated with this study.

For more information or to arrange an expert interview, please contact the ESHRE Press Office at: press@eshre.eu

 

About the European Society of Human Reproduction and Embryology

The main aim of ESHRE is to promote interest in infertility care and to aim for a holistic understanding of reproductive biology and medicine.

ESHRE collaborates world-wide and advocates universal improvements in scientific research, encourages and evaluates new developments in the field, and fosters harmonisation in clinical practice. It also provides guidance to enhance effectiveness, safety and quality assurance in clinical and laboratory procedures, psychosocial care, and promotes ethical practice. ESHRE also fosters prevention of infertility and related educational programmes and promotes reproductive rights regardless of the individual’s background. ESHRE’s activities include teaching, training, professional accreditations, mentoring and career planning for junior professionals, as well as developing and maintaining data registries. It also facilitates and disseminates research in human reproduction and embryology to the general public, scientists, clinicians, allied personnel, and patient associations.

Website: https://www.eshre.eu/

 

About Human Reproduction

Human Reproduction is a monthly journal of ESHRE and is one of the top three journals in the world in the field of reproductive biology, obstetrics and gynaecology. It is published by Oxford Journals, a division of Oxford University Press.

 

References:

Presentation “Assisted Reproductive Technology (ART) in Europe 2021 and development of a strategy of vigilance. Preliminary results generated from European registers by the ESHRE EIM Consortium, presented by J Smeenk. This is the 25th ESHRE report based on data collected and analysed by EIM, which is a group of representatives of national registries on assisted reproductive technology (ART). Since its first report in 1997, EIM has recorded almost 14 million treatments, with 2.8 million children born based on information from national registries, clinics, or professional societies. The findings have been reported in manuscripts published in Human Reproduction. Smeenk, C Wyns, C De Geyter, M Kupka, C Bergh, I Cuevas Saiz, D De Neubourg, K Rezabek, A Tandler-Schneider, I Rugescu, V Goossens ART in Europe, 2019: results generated from European registries by ESHRE, European IVF Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE), Human Reproduction, https://doi.org/10.1093/humrep/dead197 Clinical pregnancy refers to a pregnancy confirmed by an ultrasound scan that shows one or more gestational sacs – the fluid-filled structure surrounding an embryo – or definitive clinical signs of pregnancy. END



ELSE PRESS RELEASES FROM THIS DATE:

New 3D imaging method offers promise of better IVF outcomes

2024-07-09
Innovative research, presented today at the ESHRE 40th Annual Meeting in Amsterdam, has introduced a novel 3D imaging model designed to identify features of blastocysts – the early stage of development for an implanted embryo – associated with successful pregnancies. This new approach could transform current blastocyst selection methods, and open avenues for increased pregnancy rates [1]. The shape and structure of blastocysts can predict the success of a pregnancy, aiding blastocyst selection for in vitro fertilisation (IVF). However, selecting ...

Brain & Life® announces new Editor-in-Chief

2024-07-08
MINNEAPOLIS – The American Academy of Neurology (AAN) has named a new editor-in-chief of Brain & Life®, its free patient and caregiver magazine, website and podcast. Sarah Song, MD, MPH, FAAN, an associate professor in the department of neurological sciences at Rush University Medical Center in Chicago, will succeed Editor-in-Chief Orly Avitzur, MD, MBA, FAAN, who will complete her 10-year term on December 31, 2024. Song, a Fellow of the American Academy of Neurology, will be the third editor-in-chief of Brain & Life since the publication began in ...

University of Cincinnati study: Brain organ plays key role in adult neurogenesis

University of Cincinnati study: Brain organ plays key role in adult neurogenesis
2024-07-08
University of Cincinnati researchers have pioneered an animal model that sheds light on the role an understudied organ in the brain has in repairing damage caused by stroke. The research was published July 2 in the Proceedings of the National Academy of Sciences and sought to learn more about how the adult brain generates new neurons to repair damaged tissue. The research team focused on the choroid plexus, a small organ within brain ventricles that produces the brain’s cerebrospinal fluid (CSF). CSF circulates throughout ...

Small molecules induce trained immunity, opening a new approach to fighting disease

2024-07-08
Vaccines provide a front-line defense against dangerous viruses, training adaptive immune cells to identify and fight specific pathogens. But innate immune cells — the first responders to any bodily invader — have no such specific long-term memory. Still, scientists have found that they can reprogram these cells to be even better at their jobs, potentially fighting off seasonal scourges like the common cold or even new viral diseases for which vaccines have not yet been developed. A University of Chicago Pritzker School of Molecular Engineering (PME) team has found several small molecule candidates that induce this trained immunity without the ...

Erasing “bad memories” to improve long term Parkinson’s disease treatment

2024-07-08
BIRMINGHAM, Ala. — Common treatments for Parkinson’s disease can address short-term symptoms but can also cause extensive problems for patients in the long run. Namely, treatments can cause dyskinesia, a form of uncontrollable movements and postures. In a recent study published in The Journal of Neuroscience, researchers at the University of Alabama at Birmingham took a different approach to dyskinesia and treated it like a “bad motor memory.” They found that blocking a protein called Activin A could halt dyskinesia symptoms ...

Restored oyster sanctuaries host more marine life

Restored oyster sanctuaries host more marine life
2024-07-08
In the campaign to restore Chesapeake Bay, oyster sanctuaries rank among the most hotly contested strategies. But new research suggests these no-harvest areas are working, and not only for the oysters. In a new study published July 4 in Marine Ecology Progress Series, Smithsonian biologists discovered oyster sanctuaries contain more abundant populations of oysters and other animal life—and the presence of two common parasites is not preventing that. Oysters form the backbone of Chesapeake Bay. Besides injecting millions of dollars into the regional economy each year, they also act as vital habitat and filter feeders that clean the water. But their populations ...

Research spotlight: Machine learning helps identify patients at varying levels of risk for opioid use disorder

Research spotlight: Machine learning helps identify patients at varying levels of risk for opioid use disorder
2024-07-08
Ronen Rozenblum, PhD, MPH, director of the Unit for Innovative Healthcare Practice & Technology and director of Business Development of the Center for Patient Safety Research and Practice at Brigham and Women's Hospital, and an assistant professor at Harvard Medical School, is the principal investigator and senior author of a new study published in JMIR Medical Informatics, “A Machine Learning Application to Classify Patients at Differing Levels of Risk of Opioid Use Disorder: Clinician Based ...

Detroit researchers receive Department of Defense grant to assist in discovering new treatments for ovarian cancer

Detroit researchers receive Department of Defense grant to assist in discovering new treatments for ovarian cancer
2024-07-08
DETROIT — Gen Sheng Wu, Ph.D., professor of oncology in the Wayne State University School of Medicine and the Barbara Ann Karmanos Cancer Institute, recently received a grant from the U.S. Department of Defense’s Congressionally Directed Medical Research Programs. This four-year, $924,000 grant will benefit Wu’s study, “Targeting Dual-Specificity Phosphatase 1 in Platinum Resistance in Ovarian Cancer,” which aims to discover improved treatments for ovarian cancer. “Ovarian cancer ...

Acupuncture reduces methadone dose and opioid cravings in patients undergoing methadone maintenance therapy

2024-07-08
Embargoed for release until 5:00 p.m. ET on Monday 8 July 2024     Annals of Internal Medicine Tip Sheet      @Annalsofim     Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of ...

Novel compound offers improved defense against fentanyl overdoses

2024-07-08
Scientists at the University of Florida have identified a novel compound aimed at improving the treatment of opioid overdoses, which claimed the lives of more than 81,000 Americans last year. The discovery could combat the devastating epidemic of opioid-related deaths, driven predominantly by the proliferation of fentanyl. The highly potent synthetic opioid is a pain reliever and among the nation’s most abused substances. “Fentanyl is driving the need to find better treatments for opioid overdoses,” said Jay McLaughlin, Ph.D., a professor of pharmacodynamics in the UF College of Pharmacy. “Every opioid death is preventable, highlighting ...

LAST 30 PRESS RELEASES:

Caltech's new fingerprint mass spectrometry method paves the way to solving the proteome

Invasive flathead catfish impacting Susquehanna’s food chain, researchers find

Javadi receives DOE Early Career Award to study qubit hosts

Obesity Medicine Fellowship created at Pennington Biomedical

Structural biology analysis of a Pseudomonas bacterial virus reveals a genome ejection motor

Remote tool developed to helped detect autism and developmental delay in children with limited access to specialists

Texas Accounting Chair Steven Kachelmeier garners coveted award for scholarship

CABHI launches funding program that ignites innovation to advance healthy aging

A fully automated AI-based system for assessing IVF embryo quality

Senolytics dasatinib and quercetin for prevention of pelvic organ prolapse in mice

UCLA efforts to provide prostate cancer treatment in the community gets $6 million boost

Study asks: Can cell phone signals help land a plane?

Artificial intelligence is creating a new way of thinking, an external thought process outside of our minds

Reaction conditions tune catalytic selectivity

Verified users on social media networks drive polarization and the formation of echo chambers

Get a grip: The best thumb position for disc launch speed and spin rate

Maternal eating disorders, BMI, and offspring psychiatric diagnoses

Geometric mechanics shape the dog's nose

‘Visual clutter’ alters information flow in the brain

Researchers succeed in taking 3D x-ray images of a skyrmion

MRI can save rectal cancer patients from surgery, study suggests

Fyodor Urnov on clinical crisis in CRISPR genome editing

People with type 2 diabetes who eat low-carb may be able to discontinue medication

Air pollution linked to having a peanut allergy during childhood

Dangers of the metaverse and VR for US youth revealed in new research

A national indicator for a just energy transition

Cognitive effort whets the appetite for reward

European funders and organizations partner to promote sustainable research

A model for the decline of trends, fads, and information sharing

Plastic mulch is contaminating agricultural fields

[Press-News.org] IVF and IUI treatment cycles increase across Europe, along with stable pregnancy rates
Women in Europe are receiving more cycles of in vitro fertilization (IVF) and intrauterine insemination (IUI), according to data presented today at the ESHRE 40th Annual Meeting in Amsterdam